Effect of Peanut Ball Use ın Prımarıes on Labor Paın, Duratıon of Labor Anxıety and
NCT ID: NCT06804577
Last Updated: 2025-02-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
108 participants
INTERVENTIONAL
2025-01-01
2025-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Peanut Ball Application on Delivery Process
NCT06200688
Effects of Different Birthing Balls Used at the First Stage of Childbirth
NCT04827797
The Effect of Using Peanuts Balls at Birth
NCT06808620
The Peanut Ball Use on Labor
NCT06387680
Birthing Ball (Peanut Ball) Positions
NCT04729426
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Research Sample Since the effect size regarding the labor comfort and labor satisfaction scales could not be obtained from the studies conducted, sample calculations could not be made for these scales in our study (Ersoy 2011, Gau et al 2011, Akın 2016, Akın and Saydam 2020). Therefore, it was determined that 60 pregnant women should be included in each group, assuming that the effect size would be 0.6 (medium), at a 5% Type I error level, and the study power was 90%. It was determined that a total of 120 primiparous pregnant women should be included in the study sample. During the study, there were no pregnant women in either group who had an emergency cesarean section or converted from normal birth to cesarean section.
Data Collection Tools The research data were collected using the Personal Information Form to determine the sociodemographic characteristics, obstetric characteristics and preparation characteristics for birth of the pregnant women, the Visual Analog Scale (VAS) to determine the labor pains perceived by the pregnant women, the State Anxiety Scale to measure the anxiety level of the pregnant women at the time of birth and the Maternal Satisfaction Evaluation Scale for Normal Birth for birth satisfaction.
Personal Information Form The form prepared by the researcher based on the literature included 11 questions regarding the sociodemographic characteristics of the women (age, height, weight, education level, marital status, employment status, income level perception, income level, place of residence, family structure, smoking); There are 5 questions about obstetric characteristics (gestational week, abortion-curettage history, pregnancy desire, regular prenatal care, where care is received) and 6 questions about preparation for birth (receiving childbirth preparation education, where education is received, preparation for motherhood, spousal support during pregnancy, family and friend support during pregnancy, satisfaction with pregnancy) for a total of 22 questions (Ersoy 2011, Chu et al 2017, Shirazi et al 2019, Kanedi et al 2019, Hildingsson and Rubertsson 2020, Akın and Saydam 2020).
VAS (Visual Analog Scale) The scale developed by Price et al. (1983) is used to determine the severity and level of pain in the patient. The scale defines pain as "0" no pain, "10" very severe on a 10 cm straight line. The patient is asked to mark a point on this line that corresponds to the level of pain he/she will feel. Accordingly, the marked point in centimeters is evaluated as the level of pain. On the scale, "0" indicates no pain, "2" indicates mild pain, "4" moderate pain, "6" severe pain, "8" very severe pain, and "10" unbearable pain. This scoring also shows the increase in the level of pain as the numerical value increases (Price 1983). State Anxiety Inventory (SAI) Spielberger's State Anxiety Inventory: The scale, developed by Spielberg and his colleagues in 1964 to measure the level of state anxiety of normal and abnormal individuals, was adapted to Turkish by Öner and Le Compte (1983). It is a self-assessment type scale consisting of short statements. The state anxiety inventory was developed to measure a person's anxiety at a certain moment. The state anxiety inventory, consisting of 20 items, is a scale that determines how an individual feels at a certain moment and under a certain condition. The feelings or behaviors expressed in the state anxiety inventory items are answered by marking one of the following options according to their intensity: (1) not at all, (2) a little, (3) a lot, (4) completely. There are 10 reversed statements in the inventory. These statements are items 1, 2, 5, 8, 10, 11, 15, 16, 19, and 20. The state anxiety score is calculated by adding 50 points to the difference between the total weighted scores of direct statements and reverse statements. The scores obtained in the state anxiety scale theoretically vary between 20 and 80 points. In the evaluation of the scale, it is accepted that those who score below 36 have no anxiety, those who score between 37-42 have mild anxiety, and those who score 42 and above have high anxiety (14) Normal Birth Maternal Satisfaction Assessment Scale (NDAMDS) NDAMDS was developed by Güngör and Beji (190). The relevant scale consists of a total of 43 items and 10 sub-dimensions. The sub-dimensions of the scale and item numbers are; perception of the health team (items 1, 2, 3, 4), care during labor (items 5, 6), comfort (items 7, 8, 9, 10), participation in decision-making and information (items 8, 11, 12, 13, 14, 15, 16, 17-32), meeting the baby (items 19, 20, 21), postpartum care (22, 23, 24,25, 26, 27), hospital room (28, 29, 30, 31), hospital facilities (items 32, 33, 34), privacy
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Behavioral: Educational with milnacipran
IStage 1: When the cervical dilatation of the pregnant woman was 4-5 cm, DCO was applied after VAS 1 application. VAS 2 was applied 15 minutes after DKÖ 1 was applied.
Stage 2: When the pregnant woman's cervical dilatation was 6-7 cm, VAS 3 was applied by the researcher. VAS 4 was applied 15 minutes after VAS 3 was applied.
Stage 3: DKÖ 2 was applied when the pregnant woman's cervical dilatation was 7-8 cm.
Stage 4: VAS 5 was applied when the pregnant woman's cervical dilatation was 8 cm and above. VAS 6 was applied 15 minutes after VAS 5 was applied.
Stage 5: When the cervical effacement and dilation of the pregnant woman is completed and the fetal head rests on the perineum, the pregnant woman is taken to the delivery table.
Stage 6: In the fourth stage of labor, between the second and third hours, the researcher will apply DCO and NDAMDS.
peanut ball
The experimental group will use peanut balls;
control group
standard care group
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
peanut ball
The experimental group will use peanut balls;
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria Pregnant women with maternal and fetal complications (oligohydramnios and polyhydramnios, placenta previa, preeclampsia, premature membrane rupture, presentation anomalies, IUGR, fetal anomalies, intrauterine death, macrosomic baby, fetal distress, etc.) Elective cesarean section
18 Years
49 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kahramanmaras Sutcu Imam University
OTHER
Ayşe FİLİZ
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ayşe FİLİZ
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kahramanmaraş Sütçü İmam Universty
Çağlayanceri̇t, Kahramanmaraş, Turkey (Türkiye)
Kahramanmaraş Sütçü İmam Universty
Kahramanmaraş, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KahramanSIU
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.